Inspicos
Sponsored
Sponsored
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos says a Unified Patent Court decision not to stay a revocation action while a parallel EPO opposition proceeding takes place provides another indication of the court’s fast pace
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos reviews a recent decision of the EPO Legal Board of Appeal relating to the impact of an applicant’s appeal against a decision to grant a patent
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos reviews a recent referral to the EPO Enlarged of Board of Appeal relating to the impact of statements in the description on the interpretation of claims
-
Sponsored by InspicosA case concerning a payment made after the nine-month opposition period because of a problem with the EPO’s online filing software offers a useful checklist, says Edward Farrington of Inspicos
-
Sponsored by InspicosWhile concrete definitions are still lacking, Peter Koefoed of Inspicos says patent applicants seeking protection for second medical uses of products could now find it easier to build their case
-
Sponsored by InspicosSzonja Szenczi-Molnár of Inspicos explains why patent applicants should clearly explain the alternatives and possible combinations concerning claims when drafting description text, in light of a ruling on the allowability of amendments